Literature DB >> 11593403

Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation.

M Ljungman1, H M O'Hagan, M T Paulsen.   

Abstract

Blockage of transcription has been shown to induce the tumor suppressor p53 in human cells. We here show that RNA synthesis inhibitors blocking the phosphorylation of the carboxyl terminal domain (CTD) of RNA polymerase II, such as DRB and H7, induced rapid nuclear accumulation of p53 proteins that were not phosphorylated at ser15 or acetylated at lys382. In contrast, agents that inhibit the elongation phase of transcription, such as UV light, camptothecin or actinomycin D, induced the accumulation of nuclear p53 proteins that were modified at both of these sites. Furthermore, using a panel of DNA repair-deficient cells we show that persistent DNA lesions in the transcribed strand of active genes are responsible for the induction of the ser15 and lys382 modifications following UV-irradiation. We conclude that inhibition of transcription is sufficient for the accumulation of p53 in the nucleus regardless of whether the ser15 site of p53 is phosphorylated or not. Importantly, blockage of the elongation phase of transcription triggers a distinct signaling pathway leading to p53 modifications on ser15 and lys382. We propose that the elongating RNA polymerase complex may act as a sensor of DNA damage and as an integrator of cellular stress signals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593403     DOI: 10.1038/sj.onc.1204734

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Transcriptional regulation of HIV-1 gene expression by p53.

Authors:  Ruma Mukerjee; Pier Paolo Claudio; J Robert Chang; Luis Del Valle; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

Review 2.  Mitochondrial DNA damage and its consequences for mitochondrial gene expression.

Authors:  Susan D Cline
Journal:  Biochim Biophys Acta       Date:  2012-06-19

3.  RPA and ATR link transcriptional stress to p53.

Authors:  Frederick A Derheimer; Heather M O'Hagan; Heather M Krueger; Sheela Hanasoge; Michelle T Paulsen; Mats Ljungman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-06       Impact factor: 11.205

4.  Proteomic analysis of arginine methylation sites in human cells reveals dynamic regulation during transcriptional arrest.

Authors:  Kathrine B Sylvestersen; Heiko Horn; Stephanie Jungmichel; Lars J Jensen; Michael L Nielsen
Journal:  Mol Cell Proteomics       Date:  2014-02-21       Impact factor: 5.911

5.  FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence.

Authors:  Pavel Krejci; Jirina Prochazkova; Jiri Smutny; Katarina Chlebova; Patricia Lin; Anie Aklian; Vitezslav Bryja; Alois Kozubik; William R Wilcox
Journal:  Bone       Date:  2010-03-31       Impact factor: 4.398

6.  CSA and CSB proteins interact with p53 and regulate its Mdm2-dependent ubiquitination.

Authors:  Paolo Latini; Mattia Frontini; Manuela Caputo; Juraj Gregan; Lubos Cipak; Silvia Filippi; Vivek Kumar; Renier Vélez-Cruz; Miria Stefanini; Luca Proietti-De-Santis
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

7.  DNA damage-induced ATM- and Rad-3-related (ATR) kinase activation in non-replicating cells is regulated by the XPB subunit of transcription factor IIH (TFIIH).

Authors:  Michael G Kemp
Journal:  J Biol Chem       Date:  2017-06-07       Impact factor: 5.157

Review 8.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

9.  SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53.

Authors:  Cian J Lynch; Zahid H Shah; Simon J Allison; Shafiq U Ahmed; Jack Ford; Lorna J Warnock; Han Li; Manuel Serrano; Jo Milner
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

10.  The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status.

Authors:  Valentina Turinetto; Paola Porcedda; Luca Orlando; Mario De Marchi; Antonio Amoroso; Claudia Giachino
Journal:  BMC Cancer       Date:  2009-08-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.